Symbols / PRGO Stock $11.39 -4.45% Perrigo Company plc

Healthcare • Drug Manufacturers - Specialty & Generic • Ireland • NYQ
PRGO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Patrick Lockwood-Taylor
Exch · Country NYQ · Ireland
Market Cap 1.57B
Enterprise Value 4.89B
Income -1.40B
Sales 4.25B
FCF (ttm) 28.32M
Book/sh 21.33
Cash/sh 3.86
Employees 8,100
Insider 10d —
IPO Dec 17, 1991
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 109.50%
P/E —
Forward P/E 4.79
PEG 1.14
P/S 0.37
P/B 0.53
P/C —
EV/EBITDA 7.19
EV/Sales 1.15
Quick Ratio 1.17
Current Ratio 2.76
Debt/Eq 131.16
LT Debt/Eq —
EPS (ttm) -10.12
EPS next Y 2.38
EPS Growth —
Revenue Growth -2.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-02-26
ROA 2.35%
ROE -38.66%
ROIC —
Gross Margin 35.14%
Oper. Margin 10.20%
Profit Margin -33.51%
Shs Outstand 137.65M
Shs Float 136.81M
Insider Own 0.41%
Instit Own 116.14%
Short Float 15.58%
Short Ratio 3.84
Short Interest 13.92M
52W High 28.44
vs 52W High -59.95%
52W Low 9.23
vs 52W Low 23.40%
Beta 0.54
Impl. Vol. 1.31%
Rel Volume 0.41
Avg Volume 3.28M
Volume 1.33M
Target (mean) $17.00
Tgt Median $16.50
Tgt Low $15.00
Tgt High $20.00
# Analysts 4
Recom Buy
Prev Close $11.92
Price $11.39
Change -4.45%
About

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$17.00
Mean price target
2. Current target
$11.39
Latest analyst target
3. DCF / Fair value
$3.70
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$11.39
Low
$15.00
High
$20.00
Mean
$17.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-27 main Canaccord Genuity Buy → Buy $17
2025-12-15 main JP Morgan Neutral → Neutral $18
2025-11-06 main Canaccord Genuity Buy → Buy $20
2025-11-06 down JP Morgan Overweight → Neutral $20
2025-10-27 main Jefferies Hold → Hold $23
2025-08-07 main Canaccord Genuity Buy → Buy $40
2025-08-07 main JP Morgan Overweight → Overweight $35
2025-01-06 down Piper Sandler Overweight → Neutral $27
2024-09-30 main Canaccord Genuity Buy → Buy $42
2024-09-23 down Jefferies Buy → Hold $30
2024-07-11 main Piper Sandler Overweight → Overweight $35
2024-06-13 main Piper Sandler Overweight → Overweight $36
2024-04-12 main Canaccord Genuity Buy → Buy $42
2024-04-08 main Piper Sandler Overweight → Overweight $39
2024-02-28 main JP Morgan Overweight → Overweight $41
2023-11-17 init Piper Sandler — → Overweight $37
2023-08-09 main JP Morgan Overweight → Overweight $48
2023-03-07 init Canaccord Genuity — → Buy $49
2023-03-06 main Raymond James — → Outperform $43
2022-11-09 main Raymond James — → Outperform $42
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4,253.10
-2.75%
4,373.40
-6.06%
4,655.60
+4.58%
4,451.60
Operating Revenue
4,253.10
-2.75%
4,373.40
-6.06%
4,655.60
+4.58%
4,451.60
Cost Of Revenue
2,758.60
-2.55%
2,830.70
-4.86%
2,975.20
-0.70%
2,996.20
Reconciled Cost Of Revenue
2,758.60
-2.55%
2,830.70
-4.86%
2,975.20
-0.70%
2,996.20
Gross Profit
1,494.50
-3.12%
1,542.70
-8.19%
1,680.40
+15.46%
1,455.40
Operating Expense
1,181.70
-3.99%
1,230.80
-11.85%
1,396.30
+4.67%
1,334.00
Research And Development
95.40
-14.97%
112.20
-8.41%
122.50
-0.49%
123.10
Selling General And Administration
1,055.80
-5.11%
1,112.60
-12.71%
1,274.60
+5.33%
1,210.10
Selling And Marketing Expense
619.90
-3.83%
644.60
-14.32%
752.30
+7.81%
697.80
General And Administrative Expense
435.90
-6.86%
468.00
-10.40%
522.30
+1.95%
512.30
Other Gand A
435.90
-6.86%
468.00
-10.40%
522.30
+1.95%
512.30
Other Operating Expenses
30.50
+408.33%
6.00
+850.00%
-0.80
-200.00%
0.80
Total Expenses
3,940.30
-2.98%
4,061.50
-7.09%
4,371.50
+0.95%
4,330.20
Operating Income
312.80
+0.29%
311.90
+9.79%
284.10
+134.02%
121.40
Total Operating Income As Reported
-1,122.20
-1093.98%
112.90
-25.67%
151.90
+92.52%
78.90
EBITDA
-797.90
-284.27%
433.00
-17.52%
525.00
+47.68%
355.50
Normalized EBITDA
637.10
-0.25%
638.70
-2.34%
654.00
+60.73%
406.90
Reconciled Depreciation
337.50
+3.56%
325.90
-9.35%
359.50
+6.17%
338.60
EBIT
-1,135.40
-1160.13%
107.10
-35.29%
165.50
+879.29%
16.90
Total Unusual Items
-1,435.00
-597.62%
-205.70
-59.46%
-129.00
-150.97%
-51.40
Total Unusual Items Excluding Goodwill
-1,435.00
-597.62%
-205.70
-59.46%
-129.00
-150.97%
-51.40
Special Income Charges
-1,435.00
-597.62%
-205.70
-59.46%
-129.00
-150.97%
-51.40
Other Special Charges
—
6.70
+309.38%
-3.20
-135.96%
8.90
Restructuring And Mergern Acquisition
71.90
-34.70%
110.10
+160.90%
42.20
-0.71%
42.50
Write Off
1,363.10
+1433.30%
88.90
-1.22%
90.00
0.00
Net Income
-1,425.40
-729.69%
-171.80
-1252.76%
-12.70
+90.97%
-140.60
Pretax Income
-1,297.90
-1508.30%
-80.70
-872.29%
-8.30
+94.03%
-139.10
Net Non Operating Interest Income Expense
-162.50
+13.47%
-187.80
-8.06%
-173.80
-11.41%
-156.00
Interest Expense Non Operating
162.50
-13.47%
187.80
+8.06%
173.80
+11.41%
156.00
Net Interest Income
-162.50
+13.47%
-187.80
-8.06%
-173.80
-11.41%
-156.00
Interest Expense
162.50
-13.47%
187.80
+8.06%
173.80
+11.41%
156.00
Other Income Expense
-1,448.20
-607.13%
-204.80
-72.68%
-118.60
-13.49%
-104.50
Other Non Operating Income Expenses
-13.20
-1566.67%
0.90
-91.35%
10.40
+119.59%
-53.10
Tax Provision
104.40
+30.50%
80.00
+2151.28%
-3.90
+52.44%
-8.20
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+255.93%
0.00
Tax Effect Of Unusual Items
-301.35
-597.62%
-43.20
-59.46%
-27.09
-793.29%
-3.03
Net Income Including Noncontrolling Interests
-1,425.40
-729.69%
-171.80
-1252.76%
-12.70
+90.97%
-140.60
Net Income From Continuing Operation Net Minority Interest
-1,402.30
-772.62%
-160.70
-3552.27%
-4.40
+96.64%
-130.90
Net Income From Continuing And Discontinued Operation
-1,425.40
-729.69%
-171.80
-1252.76%
-12.70
+90.97%
-140.60
Net Income Continuous Operations
-1,402.30
-772.62%
-160.70
-3552.27%
-4.40
+96.64%
-130.90
Net Income Discontinuous Operations
-23.10
-108.11%
-11.10
-33.73%
-8.30
+14.43%
-9.70
Normalized Income
-268.65
-15000.17%
1.80
-98.15%
97.51
+218.15%
-82.53
Net Income Common Stockholders
-1,425.40
-729.69%
-171.80
-1252.76%
-12.70
+90.97%
-140.60
Diluted EPS
-10.29
-723.20%
-1.25
-1288.89%
-0.09
+91.35%
-1.04
Basic EPS
-10.29
-723.20%
-1.25
-1288.89%
-0.09
+91.35%
-1.04
Basic Average Shares
138.50
+0.80%
137.40
+1.55%
135.30
+0.59%
134.50
Diluted Average Shares
138.50
+0.80%
137.40
+1.55%
135.30
+0.59%
134.50
Diluted NI Availto Com Stockholders
-1,425.40
-729.69%
-171.80
-1252.76%
-12.70
+90.97%
-140.60
Total Other Finance Cost
—
—
—
—
Line Item Trend 2023-12-31
Total Assets
10,809.10
Current Assets
2,832.90
Cash Cash Equivalents And Short Term Investments
751.30
Cash And Cash Equivalents
751.30
Receivables
739.60
Accounts Receivable
739.60
Gross Accounts Receivable
747.40
Allowance For Doubtful Accounts Receivable
-7.80
Inventory
1,140.90
Raw Materials
252.20
Work In Process
241.90
Finished Goods
646.80
Prepaid Assets
—
Assets Held For Sale Current
—
Other Current Assets
201.10
Total Non Current Assets
7,976.20
Net PPE
1,100.00
Gross PPE
2,172.40
Accumulated Depreciation
-1,072.40
Properties
0.00
Land And Improvements
50.60
Buildings And Improvements
611.30
Machinery Furniture Equipment
1,326.90
Other Properties
183.60
Goodwill And Other Intangible Assets
6,515.20
Goodwill
3,529.10
Other Intangible Assets
2,986.10
Non Current Deferred Assets
25.80
Non Current Deferred Taxes Assets
25.80
Other Non Current Assets
335.20
Total Liabilities Net Minority Interest
6,041.20
Current Liabilities
1,586.30
Payables And Accrued Expenses
1,145.70
Payables
519.80
Accounts Payable
477.70
Current Accrued Expenses
625.90
Total Tax Payable
42.10
Income Tax Payable
42.10
Current Debt And Capital Lease Obligation
440.60
Current Debt
440.60
Other Current Borrowings
—
Current Capital Lease Obligation
—
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
4,454.90
Liabilities Heldfor Sale Non Current
—
Long Term Debt And Capital Lease Obligation
3,632.80
Long Term Debt
3,632.80
Long Term Capital Lease Obligation
—
Non Current Deferred Liabilities
262.30
Non Current Deferred Taxes Liabilities
262.30
Other Non Current Liabilities
559.80
Stockholders Equity
4,767.90
Common Stock Equity
4,767.90
Capital Stock
6,837.50
Common Stock
6,837.50
Preferred Stock
0.00
Share Issued
135.51
Ordinary Shares Number
135.51
Treasury Shares Number
0.00
Retained Earnings
-2,080.30
Gains Losses Not Affecting Retained Earnings
10.70
Other Equity Adjustments
10.70
Total Equity Gross Minority Interest
4,767.90
Total Capitalization
8,400.70
Working Capital
1,246.60
Invested Capital
8,841.30
Total Debt
4,073.40
Net Debt
3,322.10
Capital Lease Obligations
—
Net Tangible Assets
-1,747.30
Tangible Book Value
-1,747.30
Preferred Shares Number
0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
238.50
-34.28%
362.90
-10.51%
405.50
+31.96%
307.30
Cash Flow From Continuing Operating Activities
238.50
-34.28%
362.90
-10.51%
405.50
+31.96%
307.30
Net Income From Continuing Operations
-1,425.40
-729.69%
-171.80
-1252.76%
-12.70
+90.97%
-140.60
Depreciation Amortization Depletion
337.50
+3.56%
325.90
-9.35%
359.50
+6.17%
338.60
Depreciation And Amortization
337.50
+3.56%
325.90
-9.35%
359.50
+6.17%
338.60
Other Non Cash Items
82.80
-24.31%
109.40
+62.31%
67.40
+36.44%
49.40
Stock Based Compensation
54.60
-15.22%
64.40
-6.40%
68.80
+25.32%
54.90
Asset Impairment Charge
1,363.10
+1433.30%
88.90
-1.22%
90.00
0.00
Deferred Tax
-50.80
-618.37%
9.80
+109.19%
-106.60
-111.09%
-50.50
Deferred Income Tax
-50.80
-618.37%
9.80
+109.19%
-106.60
-111.09%
-50.50
Operating Gains Losses
1.60
-92.42%
21.10
+614.63%
-4.10
-111.55%
35.50
Gain Loss On Investment Securities
—
55.60
—
—
Net Foreign Currency Exchange Gain Loss
—
0.00
0.00
-100.00%
39.40
Change In Working Capital
-101.10
-35.34%
-74.70
-27.69%
-58.50
-392.50%
20.00
Change In Receivables
30.70
+376.58%
-11.10
+80.56%
-57.10
-57200.00%
0.10
Changes In Account Receivables
30.70
+376.58%
-11.10
+80.56%
-57.10
-57200.00%
0.10
Change In Inventory
-61.10
-545.99%
13.70
-29.38%
19.40
+125.29%
-76.70
Change In Prepaid Assets
8.40
-58.21%
20.10
-57.68%
47.50
+83.40%
25.90
Change In Payables And Accrued Expense
-78.90
+20.22%
-98.90
+2.85%
-101.80
-386.76%
35.50
Change In Accrued Expense
-106.10
+12.53%
-121.30
-427.39%
-23.00
-36.09%
-16.90
Change In Payable
27.20
+21.43%
22.40
+128.43%
-78.80
-250.38%
52.40
Change In Account Payable
-28.70
-152.95%
54.20
+182.25%
-65.90
-165.70%
100.30
Change In Other Working Capital
—
1.50
-94.21%
25.90
-26.42%
35.20
Change In Other Current Liabilities
-0.20
0.00
-100.00%
7.60
—
Investing Cash Flow
-75.40
-195.69%
78.80
+201.68%
-77.50
+96.04%
-1,958.60
Cash Flow From Continuing Investing Activities
-75.40
-195.69%
78.80
+201.68%
-77.50
+96.04%
-1,958.60
Net PPE Purchase And Sale
-93.40
+21.05%
-118.30
-16.32%
-101.70
-5.50%
-96.40
Purchase Of PPE
-93.40
+21.05%
-118.30
-16.32%
-101.70
-5.50%
-96.40
Capital Expenditure
-93.40
+21.05%
-118.30
-16.32%
-101.70
-5.50%
-96.40
Net Investment Purchase And Sale
0.00
+100.00%
-48.20
0.00
-100.00%
61.70
Purchase Of Investment
0.00
+100.00%
-48.20
0.00
—
Sale Of Investment
—
—
0.00
-100.00%
61.70
Net Business Purchase And Sale
14.40
-93.32%
215.50
0.00
+100.00%
-1,952.70
Purchase Of Business
—
0.00
0.00
+100.00%
-2,011.40
Gain Loss On Sale Of Business
1.60
+125.00%
-6.40
0.00
-100.00%
1.40
Net Intangibles Purchase And Sale
5.60
+7.69%
5.20
-73.74%
19.80
+500.00%
3.30
Net Other Investing Changes
-2.00
-108.13%
24.60
+459.09%
4.40
-82.75%
25.50
Financing Cash Flow
-220.50
+63.91%
-611.00
-226.39%
-187.20
-144.40%
421.60
Cash Flow From Continuing Financing Activities
-220.50
+63.91%
-611.00
-226.39%
-187.20
-144.40%
421.60
Net Issuance Payments Of Debt
-34.80
+92.05%
-437.80
-1349.67%
-30.20
-104.90%
616.70
Issuance Of Debt
0.00
-100.00%
1,091.20
+269.77%
295.10
-81.41%
1,587.30
Repayment Of Debt
-34.80
+97.72%
-1,529.00
-370.03%
-325.30
+66.48%
-970.60
Long Term Debt Issuance
0.00
-100.00%
1,091.20
+269.77%
295.10
-81.41%
1,587.30
Long Term Debt Payments
-34.80
+97.72%
-1,529.00
-370.03%
-325.30
+66.48%
-970.60
Net Long Term Debt Issuance
-34.80
+92.05%
-437.80
-1349.67%
-30.20
-104.90%
616.70
Net Short Term Debt Issuance
—
—
—
-11.70
Net Common Stock Issuance
—
—
—
0.00
Common Stock Payments
—
—
—
0.00
Common Stock Dividend Paid
—
—
-149.70
-5.13%
-142.40
Cash Dividends Paid
-159.30
-4.46%
-152.50
-1.87%
-149.70
-5.13%
-142.40
Repurchase Of Capital Stock
—
—
—
0.00
Net Other Financing Charges
-26.40
-27.54%
-20.70
-183.56%
-7.30
+86.15%
-52.70
Changes In Cash
-57.40
+66.10%
-169.30
-220.24%
140.80
+111.45%
-1,229.70
Effect Of Exchange Rate Changes
32.50
+240.09%
-23.20
-336.73%
9.80
+120.04%
-48.90
Beginning Cash Position
558.80
-25.62%
751.30
+25.07%
600.70
-67.79%
1,864.90
End Cash Position
531.60
-4.87%
558.80
-25.62%
751.30
+25.07%
600.70
Free Cash Flow
145.10
-40.68%
244.60
-19.49%
303.80
+44.05%
210.90
Interest Paid Supplemental Data
202.00
-19.65%
251.40
-9.21%
276.90
+27.60%
217.00
Income Tax Paid Supplemental Data
98.90
-36.48%
155.70
+44.84%
107.50
+7.29%
100.20
Amortization Of Securities
-23.80
-135.64%
-10.10
-694.12%
1.70
—
Change In Income Tax Payable
55.90
+275.79%
-31.80
-146.51%
-12.90
+73.07%
-47.90
Change In Tax Payable
55.90
+275.79%
-31.80
-146.51%
-12.90
+73.07%
-47.90
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
Other Cash Adjustment Outside Changein Cash
-2.30
0.00
0.00
-100.00%
14.40
Sale Of Business
14.40
-93.32%
215.50
0.00
-100.00%
58.70
Sale Of Intangibles
5.60
+7.69%
5.20
-73.74%
19.80
+500.00%
3.30
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category